Pharmacokinetics and ocular disposition of paracetamol and paracetamol glucuronide in rabbits with diabetes mellitus induced by alloxan.
Journal Title: Pharmacological Reports - Year 2012, Vol 64, Issue 2
Abstract
Background: This study evaluates the pharmacokinetics (PK) and ocular disposition of paracetamol and paracetamol glucuronide in diabetic rabbits. Methods: Thirty two New Zealand rabbits were divided into four groups: control group (I, n = 8), control group with diabetes (II, n = 8), rabbits with diabetes receiving paracetamol (III, n = 8), rabbits without diabetes receiving paracetamol (IV, n = 8). To induce diabetes mellitus, alloxan was administrated intravenously (iv) in the dose of 90 mg/kg body weight (b.w.) to 16 rabbits (groups II and III). Eight weeks post induction of the diabetic state, paracetamol was administrated via the ear vein at a dose of 35 mg/kg b.w. to groups III and IV. Blood and aqueous (ocular fluid) samples were collected after drug administration. PK calculations were made based on non-compartmental analysis. Results: Significant differences were observed in PK of paracetamol between the studied groups. Lower value of the area under the concentration - time curve and enhanced clearance of paracetamol were noted in the diabetic group. In the case of paracetamol glucuronide , the area under the concentration - time curve was also little lower; however, no changes in the elimination rate were observed. Simultaneously, diminished ocular disposition of paracetamol was obtained in the diabetic group, whereas no changes were noted according to the penetration of paracetamol glucuronide. Conclusions: The PK as well as ocular disposition of paracetamol may be altered in non-treated diabetes mellitus. The glucuronidation does not seem to be the process responsible for these changes.
Authors and Affiliations
Agnieszka Bienert, Jan Olszewski, Joanna Gracz, Tomasz Grabowski, Anna Wolc, Edmund Grześkowiak
Keywords
Related Articles
- EP ID EP140404
- DOI -
- Views 91
- Downloads 0
Antioxidant treatment normalizes renal Na(+),K(+)-ATPase activity in leptin-treated rats.
Hyperleptinemia may be involved in the pathogenesis of obesity-associated hypertension, however, the mechanism of hypertensive effect of leptin is incompletely elucidated. Previously, we have demonstrated that chronic hy...
Chronic unpredictable stress-induced reduction in the hippocampal brain-derived neurotrophic factor (BDNF) gene expression is antagonized by zinc treatment.
Preclinical data indicate the antidepressant activity of zinc and the involvement of the brain-derived neurotrophic factor (BDNF) in this mechanism. The present study investigates the effect of chronic (16 days) combined...
Characteristics of adrenaline-driven receptor-mediated signals in human microvessel-derived endothelial cells.
Adrenaline (0.001-1,000 muM) strongly stimulated adenosine-3',5'cyclic monophosphate (cAMP) generation in cultured human microvascular-derived endothelial cells (HMEC-1). Isoprenaline mimicked the action of adrenaline, w...
MDR1 (ABCB1) gene polymorphism C3435T is associated with P-glycoprotein activity in B-cell chronic lymphocytic leukemia.
Functional single nucleotide polymorphism (SNP) C3435T in exon 26 of the MDR1 (ABCB1) gene encoding the xenobiotic transporter P-glycoprotein (P-gp, MDR1, ABCB1) may influence susceptibility to several diseases as well a...
Effect of two behavioral tests on corticosterone level in plasma of mice lacking the noradrenaline transporter.
In the present study, we investigated plasma corticosterone levels of genetically modified mice lacking noradrenaline transporter (NET(-/-)), in response to the forced swim test (FST) and tail suspension test (TST). FST...